STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #460 by analyst upside · 2026-08-13
EYPT
EyePoint, Inc.
Healthcare · Market Cap $1B · P/E 0x
ANALYST PRICE TARGET
+202.5%
implied upside to consensus target
Current Price $13.53
Consensus Target $40.93
Bull Target $68.0
Bear Target $20.0
Analysts Covering 14
ANALYST CONSENSUS - BUY
Strong Buy
3
Buy
11
Hold
0
Sell
0
52-Week Low $9.65
52-Week High $19.11
YTD Return -22.6%
FUNDAMENTALS
Market Cap $1B
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-3.75
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $3M
Profit Margin N/A
52-WEEK RANGE
52-Week Low $9.65
52-Week High $19.11
Current Price $13.53
Bear Target $20.0
Bull Target $68.0
● Now $13.53 ● Target $40.93
TRADING DATA
Avg Volume 1.4M
YTD Return -22.6%
Analyst Count 14
Consensus Buy
Upside to Target +202.5%
Last Updated 2026-08-13

ANALYST SUMMARY

EyePoint, Inc. (EYPT) is currently trading at $13.53 with a Wall Street consensus price target of $40.93, implying potential upside of 202.5% over the next 12 months. 14 analysts currently cover EYPT, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $68.0, while the most cautious has a target of $20.0.

EYPT operates in the Healthcare sector with a market capitalisation of $1B. The stock is down 22.6% year-to-date and is currently trading near the lower end of its 52-week range of $9.65 – $19.11.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for EYPT, with each firm's 90-day track record across all stocks we track. See full firm rankings →

RBC Capital - Reiterated
Outperform → Outperform 2026-05-07 Building track record
Citigroup - Reiterated
Buy → Buy 2026-03-09 Building track record
HC Wainwright & Co. - Reiterated
Buy → Buy 2026-03-05 31% win rate (48 calls)
Chardan Capital - Reiterated
Buy → Buy 2026-03-04 33% win rate (6 calls)
RBC Capital - Reiterated
Outperform → Outperform 2025-11-06 Building track record
Chardan Capital - Reiterated
Buy → Buy 2025-08-07 33% win rate (6 calls)
HC Wainwright & Co. - Reiterated
Buy → Buy 2025-08-06 31% win rate (48 calls)
RBC Capital ● Initiated
Outperform 2025-06-17 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
48
out of 100
Coverage depth
21/30
Consensus clarity
0/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →